Loading...
OTC Markets
Totals
Securities
12,304
Dollar Vol
$2.5B
Share Vol
3.8B
Trades
319,611

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

RDGL
Vivos Inc.

Common Stock

0.1188

-0.00062

-0.52%

0.117 / 0.12 (12000 x 5000)

Real-Time Best Bid & Ask: 05:00pm 06/13/2025
Delayed (15 Min) Trade Data: 12:00am 06/13/2025

0.1188

0.116 - 0.122

249,784

Market Cap calculated only for this class of securities.

53,877,253

Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Vivos Inc. Company Logo
Vivos Inc developed a Y-90 brachytherapy product called Precision Radionuclide TherapyTM. It is designated as "Breakthrough" by the FDA. There is an ongoing clinical trial in humans in India and multiply animal therapies for horses, dogs, cats, and exotics in a growing number of certified clinics across the United States.
Videos
OTCQB Venture Market Logo
Joined OTCQB 09/2019
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.